Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

NCT05432960 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study halted according to the Sponsor's descision.

Conditions

Adult-Onset Still's Disease
AOSD

Interventions

BIOLOGICAL: RPH-104
DRUG: Placebo

Sponsor

R-Pharm International, LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]